Drugs / Liposomal iron
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01864161 | Oct 2011 → May 2013 | chronic kidney disease, iron deficiency anemia | Federico II University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07366502 | Sep 2025 → Jul 2026 overdue | disorder of iron metabolism and transport, iron deficiency anemia | Medeni Şermet | Recruiting | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 1 | NCT07667205 Comparator | Jul 2025 overdue | iron deficiency anemia | Ain Shams University | Enrolling by invitation | No outcome recorded |
| Phase 3 | NCT07556731 Comparator | May 2026 → May 2027 expected | iron deficiency anemia, iron metabolism disease | Hospital General de Mexico | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06556134 Comparator | Jul 2021 → Jul 2023 | anemia due to chronic disorder | Centre Hospitalier Hassan II - Fès | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liposomal iron | “Liposomal iron, a new generation oral iron with high gastrointestinal absorption and bioavailability and a low incidence of side effects, seems to be a promising new strategy...” PMID 25395392 ↗ Nov 2014 |
| Known as | Novofer | “Daily Liposomal group iron: will receive liposomal iron (Novofer (8mg/ml)) every day,seven drops per kilogram.” NCT07667205 ↗ |
| Route | Oral | “oral liposomal iron” NCT01864161 ↗ |